Logo image of CNTB

CONNECT BIOPHARMA HOLDINGS L (CNTB) Stock Analyst Ratings

NASDAQ:CNTB - Nasdaq - US2075231017 - ADR - Currency: USD

0.8701  +0.01 (+1.17%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to CNTB. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 8.16. This target is 837.82% above the current price.
CNTB was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CNTB.
In the previous month the buy percentage consensus was at a similar level.
CNTB was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

CNTB Historical Analyst RatingsCNTB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -45 -41 -37 -33 -29 -25 -21 -17 -13 -9 -5 -1 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 0.878.088.168.168.40 - 828.63% 837.82% 837.82% 865.41%

Related screens

CNTB Current Analyst RatingCNTB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2024-09-06 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-13 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-17 HC Wainwright & Co. Maintains Buy -> Buy
2024-03-04 HC Wainwright & Co. Initiate Buy
2023-09-13 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-02-08 SVB Leerink Maintains Outperform
2022-06-02 Cantor Fitzgerald Initiate Overweight
2022-05-05 Piper Sandler Downgrade Overweight -> Neutral
2022-05-04 SVB Leerink Maintains Outperform
2022-01-06 SVB Leerink Maintains Outperform
2021-07-02 CICC Initiate Outperform
2021-04-13 SVB Leerink Initiate Outperform
2021-04-13 Jefferies Initiate Buy